Robenidine is a veterinary drug used in the poultry industry to treat coccidiosis
caused by parasites in the
Eimeria
genus. Though this compound and
related aminoguanidines have recently been studied in other pathogens, the chemotype has
not been systematically explored to optimize antimalarial activity despite the close
genetic relationship between
Eimeria
and
Plasmodium
(both are members of the Apicomplexa phylum of unicellular, spore-forming parasites). In
this study, a series of aminoguanidine robenidine analogues was prepared and tested
in vitro
against
Plasmodium falciparum
, including
multidrug-resistant strains. Selected compounds were further evaluated
in
vivo
against murine
Plasmodium yoelii
in mice. Iterative
structure–activity relationship studies led to the discovery of
1
,
an aminoguanidine with excellent activity against drug-resistant malaria
in
vitro
and impressive
in vivo
efficacy with an
ED
50
value of 0.25 mg/kg/day in a standard 4-day test.